Vivani Medical price target lowered to $3.50 from $4 at H.C. Wainwright

2 hours ago 2

TipRanks

Wed, April 1, 2026 astatine 10:51 AM CDT 1 min read

H.C. Wainwright expert Yi Chen lowered the firm’s price target connected Vivani Medical (VANI) to $3.50 from $4 and keeps a Buy standing connected the shares aft the institution precocious reported its 2025 results, citing an accrued stock number for the firm’s lowered target. The steadfast believes NPM-139 is uniquely positioned to perchance connection efficacy comparable to Wegovy portion requiring lone erstwhile oregon doubly yearly administration, the expert tells investors.

Unlock hedge fund-level information and almighty investing tools for smarter, sharper decisions
Discover top-performing banal ideas and upgrade to a portfolio of marketplace leaders with Smart Investor Picks

Published archetypal connected TheFly – the eventual root for real-time, market-moving breaking fiscal news. Try Now>>

See Insiders’ Hot Stocks connected TipRanks >>

Read More connected VANI:

Disclaimer & DisclosureReport an Issue

Vivani: Solid Funding Runway and Strategic Catalysts Underpin Buy Rating
Vivani Medical, Inc. (VANI) Q4 Earnings Cheat Sheet

Read Entire Article